论文部分内容阅读
目的观察养心氏片联合倍他乐克治疗老年冠心病的临床疗效。方法选择2009年3月至2011年9月在我中心治疗的老年冠心病患者86例作为观察对象,随机分为治疗组和对照组,两组病例在对症治疗的基础上,治疗组:口服养心氏片每次3片,每日3次、倍他乐克每次12.5mg,每日2次;对照组:口服倍他乐克每次12.5mg,每日2次;疗程均为12周。服药前后分别观察血脂、心功能、血压、心电图、临床症状等变化指标,并作为疗效评价的依据结果治疗组:血压、胸痛、胸闷、心悸、气短、心功能、心电图等指标较对照组有明显改善,总有效率为77.8%,对照组为56.1%,两组有显著性差异(P<0.05)。结论养心氏片联合倍他乐克治疗老年冠心病疗效确切。
Objective To observe the clinical effects of Yangxin tablets combined with Betaloc on elderly patients with coronary heart disease. Methods Eighty-six elderly patients with CHD who were treated in our center from March 2009 to September 2011 were randomly divided into treatment group and control group. On the basis of symptomatic treatment, the two groups were treated with oral administration Heart tablets each 3, 3 times a day, Betaloc 12.5mg, 2 times a day; control group: Betaloc twice daily oral dose of 12.5mg; treatment for 12 weeks . Blood pressure, heart function, blood pressure, electrocardiogram, clinical symptoms and other changes were observed before and after taking the medication and as the basis for the evaluation of efficacy. The treatment group: blood pressure, chest pain, chest tightness, palpitations, shortness of breath, cardiac function, ECG and other indicators than the control group The total effective rate was 77.8% in the control group and 56.1% in the control group, with significant difference between the two groups (P <0.05). Conclusion Yang Xin tablets combined with Betaloc in the treatment of elderly patients with coronary heart disease is effective.